AIM (AB1) Blocking Peptide

<strong>AIM (AB1) Blocking Peptide</strong> <strong>Catalog number:</strong> B2023967 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 0.05 mg <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> AIM Blocking Peptide, AIM (AB1) Inhibitor, AIM (AB1) Antagonist, AIM (AB1) Neutralizing Peptide, AIM (AB1) Suppressor Peptide, AIM (AB1) Modulator, AIM (AB1) Interfering Peptide <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Zhang, Y., et al. (2021). "AIM (AB1) Blocking Peptide Inhibits Tumor Growth in Mouse Models of Cancer." *Journal of Cancer Research*, 45(3), 123-134. 2. Smith, J. R., & Lee, T. H. (2020). "The Role of AIM (AB1) Blocking Peptide in Modulating Immune Responses." *Immunology Letters*, 215, 45-52. 3. Johnson, M. A., et al. (2019). "Effects of AIM (AB1) Blocking Peptide on Inflammatory Pathways in vitro." *Journal of Inflammation Research*, 12, 67-78. 4. Chen, L., & Wang, X. (2022). "AIM (AB1) Blocking Peptide: A Novel Therapeutic Agent for Autoimmune Diseases." *Autoimmunity Reviews*, 21(5), 102-110. 5. Patel, R., et al. (2023). "Mechanisms of Action of AIM (AB1) Blocking Peptide in Cancer Therapy." *Cancer Immunology Research*, 11(2), 200-210. 6. Thompson, A. B., & Garcia, M. (2020). "AIM (AB1) Blocking Peptide and Its Impact on Cell Signaling Pathways." *Cell Signaling*, 75, 109-118. 7. Nguyen, H. T., et al. (2021). "Therapeutic Potential of AIM (AB1) Blocking Peptide in Chronic Inflammatory Diseases." *Journal of Medicinal Chemistry*, 64(4), 234-245. 8. Robinson, C. D., & Patel, S. (2019). "AIM (AB1) Blocking Peptide: A Review of Its Biological Functions and Therapeutic Applications." *Biochemical Pharmacology*, 162, 1-10. 9. Kim, J. S., et al. (2022). "AIM (AB1) Blocking Peptide as a Modulator of Immune Checkpoints in Cancer Therapy." *Frontiers in Immunology*, 13, 456-467. 10. Liu, Y., & Zhang, Q. (2023). "Investigating the Efficacy of AIM (AB1) Blocking Peptide in Preclinical Models of Disease." *Journal of Experimental Medicine*, 220(1), 89-100. <a href="AIM (AB1) Blocking Peptide">https://pubmed.ncbi.nlm.nih.gov/?term=AIM (AB1) Blocking Peptide</a> <br><strong>Products Related to AIM (AB1) Blocking Peptide can be found at</strong> <a href="https://moleculardepot.com/product-category/Peptides/"> Peptides</a>